Design and synthesis of new linear and cyclic bradykinin antagonists

Journal of Medicinal Chemistry

Volumn 39, Issue 10, 1996, Pages 2095-2101

  Thurieau, Christophe ^a   Félétou, Michel ^a   Hennig, Philippe ^a   Raimbaud, Eric ^a   Canet, Emmanuel ^a   Fauchère, Jean Luc ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

[[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE; BRADYKININ ANTAGONIST; BRADYKININ RECEPTOR; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 7 DEXTRO PHENYLALANINE]; ICATIBANT;

ANALGESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; HUMAN; HUMAN CELL; JUGULAR VEIN; NONHUMAN; RABBIT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SMOOTH MUSCLE CONTRACTION; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; ANIMALS; DRUG DESIGN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PEPTIDES, CYCLIC; RABBITS; RECEPTORS, BRADYKININ;

EID: 0029948556     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950682e     Document Type: Article

References (35)

1. Symbols and abbreviations are in accordance with recommendations of the IUPAC-IUB Joint Commission on Biomedical Nomenclature (Nomenclature and Symbolism for Amino Acids and Peptides. Biochem. J. 1984, 219, 345-373): AAA, amino acid analysis; B1, bradykinin receptor subtype 1; B2, bradykinin receptor subtype 2; Abu, 4-aminobutyric acid; aminodecanoic, 10-aminodecanoic acid; Bal, β-alanine; tBu, tert-butyl; DCC, N,N′-dicyclohexylcarbodiimide; DMF, dimethylformamide; FAB, fast atom bombardment; Fmoc, 9-fluorenylmethoxycarbonyl; GuaAbu, 4-guanidinobutyric acid; GuaCapro, 5-guanidinocaproic acid; Guavaleric, 6-guanidinovaleric acid; Hyp, hydroxyproline; NMM, N-methylmorpholine; Oic, L-3as,7as-octahydroindole-2-carboxylic acid; Tic, 1,2,3,4-tetraisoquinoline-3-carboxylic acid; TBTU, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate; TFA, trifluoroacetic acid; Thi, tetrahydro-1,4-thiazine-3-carboxylic acid.
2. Steranka, L. R.; Manning, D. C.; Dehaas, C. J.; Ferkany, J. W.; Borosky, S. A.; Connor, J. R.; Vavrek, R. J.; Stewart, J. M.; Snyder, S. H. Bradykinin as a Pain Mediator: Receptors are Localized to Sensory Neurons have Analgesic Actions. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 3245-3249.
3. Proud, D.; Kaplan, A. D. Kinin Formation: Mechanisms and Role in Inflammatory Disorders. Annu. Rev. Immunol. 1988, 6, 49-83.
4. Bhoola, K. D.; Figueroa, C. D.; Worthy, K. Bioregulation of Kinins: Kalllikreins, Kininogens and Kininases. Pharmacol. Rev. 1992, 44, 1-80.
5. Hess, J. F.; Borkowski, J. A.; Young, G. S.; Strader, C. D.; Ramsom, R. W. Cloning and Pharmacological Characterization of a Human Bradykinin (BK-2) Receptor. Biochem. Biophys. Res. Commun. 1992, 184, 260-268.
6. Menke, J. G.; Borkowski, J. A.; Bierilo, K. K.; MacNeil, T.; Derrick, A. W.; Schneck, K. A.; Ransom, R. W.; Strader, C. D.; Linemeyer, D. L.; Hess, J. F. Expresion Cloning of a Human B1 Bradykinin Receptor. J. Biol. Chem. 1994, 269, 21583-21586.
7. Farmer, S. G.; McMillan, B. A.; Meeker, S. N.; Burch, R. M. Induction of Vascular Smooth Muscle Bradykinin B1 Receptors in Vivo During Antigen Arthritis. Agents Actions 1991, 34, 191-193.
8. Regoli, D.; Barabé, J. Pharmacology of Bradykinin and Related Kinins. Pharmacol. Rev. 1980, 32, 1-46.
9. Hock, F. G.; Wirth, K.; Albus, U.; Linz, W.; Gerhards, H. J.; Wiemer, G.; Henke, St.; Breipohl, G.; König, W.; Knolle, J.; Schölkens, B. A. HOE 140 a New, Potent and Long-acting Bradykinin Antagonist: In Vitro Studies. Br. J. Pharmacol. 1991, 102, 769-773.
10. Wirth, K.; Hock, F. G.; Albus, U.; Linz, W.; Alperman, H. G.; Anagnostopoulos, H.; Henke, St.; Breipohl, G.; König, W.; Knolle, J.; Schölkens, B. A. HOE 140 a New, Potent and Long-acting Bradykinin Antagonist: In Vivo Studies. Br. J. Pharmacol. 1991, 102, 774-777.
11. Félétou, M.; Germain, M.; Thurieau, C.; Fauchère, J.-L.; Canet, E. Agonistic and Antagonistic Properties of the Bradykinin B2 Receptor Antagonist HOE 140, in Isolated Blood Vessels from Different Species. Br. J. Pharmacol. 1994, 112, 683-689.
12. Thurieau, C.; Félétou, M.; Canet, E.; Fauchère, J. L. p-Guanidinobenzoyl-[Hyp3, Thi5, D-Tic7, Oic8] Bradykinin is almost Completely Devoid of the Agonistic Effect of HOE 140 on the Endothelium-free Femoral Artery of the Sheep. Bioorg. Med. Chem. Lett. 1994, 4, 781-784.
13. Salvino, J. M.; Seoane, P. R.; Douty, B. D.; Awad, M. M.; Dolle, R. E.; Houck, W. T.; Faunce, D. M.; Sawutz, D. G. Design of Potent Non-Peptide Competitive Antagonists of the Human Bradykinin B2 Receptor. J. Med. Chem. 1993, 36, 2583-2584.
14. Thurieau, C.; et al. Unpublished results.
15. Kyle, D. J.; Blake, P. R.; Smithwick, D.; Green, L. M.; Martin, J. A.; Sinsko, J. A.; Summers, M. F. NMR and Computational Evidence That High-Affinity Bradykinin Receptor Antagonist-sAdopt C-Terminal β-Turns. J. Med. Chem. 1993, 36, 1450-1460.
16. Chakravarty, S.; Wilkins, D.; Kyle, D. J. Design of Potent, Cyclic Peptide Bradykinin Receptor Antagonists from Conformationally Constrained Linear Peptides. J. Med. Chem. 1993, 36, 2569-2571.
17. Seyfarth, F.; Felipe Pineda De Castro, L.; Liepina, I.; Paegelow, I.; Liebmann, C.; Reissmann, S. New Cyclic Bradykinin Antagonists Containing Disulfide and Lactam Bridges at the N-terminal Sequence. Int. J. Pept. Protein Res. 1995, 46, 155-165.
18. Kyle, D. J.; Chakravarty, S.; Sinsko, J. A.; Stormann, T. M. A proposed Model of Bradykinin Bound to the Rat B2 Receptor and its Utility for Drug Design. J. Med. Chem. 1994, 37, 1347-1354.
19. Barany, G.; Merrifield, R. B. In The Peptides, Analysis, Synthesis and Biology; Gross, E., Meienhofer, J., Eds.; Academic Press: New York, 1979; Vol. 2, pp 3-284.
20. Carpino, L. A.; Han, G. Y. The 9-Fluorenylmethoxycarbonyl Amino-Protecting Group. J. Org. Chem. 1972, 37, 3404-3409.
21. Vincent, M.; Remond, G.; Portevin, B.; Serkiz, B.; Laubie, M. Stereoselective synthesis of a new perhydroindole derivative of chiral iminoacid, a potent inhibitor of angiotensin converting enzyme. Tetrahedron Lett. 1982, 23, 1677-1680.
22. König, W.; Geiger, R. Chem. Ber. 1970, 103, 788-798.
23. Knorr, R.; Trzeciak, A.; Baannwarth, W.; Gillessen, D. New Coupling Reagents in Peptide Chemistry. Tetrahedron Lett. 1989, 30, 1927-1930.
24. Bernatowitcz, M. S.; Wu, Y.; Matsueda, G. R. 1H-Pyrazole-1-carboxamidine Hydrochloride: An Attractive Reagent for Guanylation of Amines and Its Application to Peptide Synthesis. J. Org. Chem. 1992, 57, 2497-2502.
25. Loffet, A.; Zhang, H. X. Allyl-based groups for side-chain protection of amino-acids. Int. J. Pept. Protein Res. 1993, 42, 346-351.
26. Félétou, M.; Martin, C. A.; Molinard, M.; Naline, E.; Germain, M.; Thurieau, C.; Fauchère, J.-L.; Canet, E.; Advenier, C. In vitro effects of HOE 140 in Human Bronchial and Vascular Tissue. Eur. J. Pharmacol. 1995, 274, 57-64.
27. Guba, W.; Haessner, R.; Breipohl, G.; Henke, S.; Knolle, J.; Santagada, V.; Kessler, H. Combined Approach of NMR and Molecular Dynamics within a Biphasic Membrane Mimetic: Conformation and Orientation of the Bradykinin Antagonist HOE 140. J. Am. Chem. Soc. 1994, 116, 7532-7540.
28. Rose, G. D.; Gierash, L. M.; Smith, J. A. Turns in Peptides and Proteins. Adv. Protein Chem. 1985, 37, 1-109.
29. Valle, G.; Kazmierski, W. M.; Crisma, M.; Bonora, G. M.; Tonolio, C.; Hruby, V. J. Constrained Phenylalanine analogues. Int. J. Pept. Protein Res. 1992, 40, 222-232.
30. Dewar, M. J. S.; Zoebish, E. G.; Healy, E. F.; Stewart, J. P. AM1: A New General Purpose Quantum Mechanical Molecular Model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
31. Kyle, D. J.; Hicks, R. P.; Blake, P. R.; Klimkowski, V. J. Conformational properties of bradykinin and bradykinin antagonists. In Bradykinin antagonists: Basic and Clinical Research; Burch, R. M., Ed.; Marcel Dekker: New York, 1990; pp 131-146.
32. Powell, M. J. D. Restart procedures for the conjugate gradient method. Math. Program. 1977, 12, 241-254.
33. Clark, M.; Cramer, R. D.; Van Opdenbosh, N. Validation of the Tripos 5.2 force field. J. Comput. Chem. 1989, 10, 241-254.
34. Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghio, C.; Alagona, G.; Profeta, S.; Weiner, P. A new force field for molecular mechanical simulation of the nucleic acids and proteins. J. Am. Chem. Soc. 1984, 106, 765-784.
35. 2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci. 1979, 25, 637-654.